Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic Dermatitis
Clinical trial NCT03954158 · COMPLETED
Trial details
- NCT number
- NCT03954158
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-15
- Primary completion
- 2019-12-16
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.